Primary Recipient

DANA-FARBER CANCER INSTITUTE, INC.

Amount

$798,964.00

Award Date

8/11/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The overall objective of this U01 application from the Dana-Farber/Harvard Cancer Center (DF/HCC) is to provide clinical and scientific experience and patient resources to perform Phase I single agent clinical trials* Phase I agent combination clinical tr

Recipients Connected to Award

Recipient	Role	Amount
DANA-FARBER CANCER INSTITUTE, INC.	Primary recipient	$751,394.36
UNIVERSITY OF CHICAGO, THE	Sub-recipient	$47,569.64